Page last updated: 2024-08-26
equol and hydrazine
equol has been researched along with hydrazine in 1 studies
Research
Studies (1)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
Authors
| Authors | Studies |
|---|---|
| Garrido, A; Muñoz, Y; Valladares, L | 1 |
Other Studies
1 other study(ies) available for equol and hydrazine
| Article | Year |
|---|---|
Equol is more active than soy isoflavone itself to compete for binding to thromboxane A(2) receptor in human platelets.
Topics: Binding, Competitive; Bridged Bicyclo Compounds, Heterocyclic; Calcium; Equol; Fatty Acids, Unsaturated; Genistein; Humans; Hydrazines; Isoflavones; Platelet Activation; Platelet Aggregation; Platelet Aggregation Inhibitors; Receptors, Thromboxane A2, Prostaglandin H2 | 2009 |